title: Self-inactivating alpharetroviral vectors with a split-packaging design.
abstract: Accidental insertional activation of proto-oncogenes and potential vector mobilization pose serious challenges for human gene therapy using retroviral vectors. Comparative analyses of integration sites of different retroviral vectors have elucidated distinct target site preferences, highlighting vectors based on the alpharetrovirus Rous sarcoma virus (RSV) as those with the most neutral integration spectrum. To date, alpharetroviral vector systems are based mainly on single constructs containing viral coding sequences and intact long terminal repeats (LTR). Even though they are considered to be replication incompetent in mammalian cells, the transfer of intact viral genomes is unacceptable for clinical applications, due to the risk of vector mobilization and the potentially immunogenic expression of viral proteins, which we minimized by setting up a split-packaging system expressing the necessary viral proteins in trans. Moreover, intact LTRs containing transcriptional elements are capable of activating cellular genes. By removing most of these transcriptional elements, we were able to generate a self-inactivating (SIN) alpharetroviral vector, whose LTR transcriptional activity is strongly reduced and whose transgene expression can be driven by an internal promoter of choice. Codon optimization of the alpharetroviral Gag/Pol expression construct and further optimization steps allowed the production of high-titer self-inactivating vector particles in human cells. We demonstrate proof of principle for the versatility of alpharetroviral SIN vectors for the genetic modification of murine and human hematopoietic cells at a low multiplicity of infection.
authors.affiliation: Experimental Hematology, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany.
authors.forename: Julia D
authors.initials: JD
authors.lastname: Suerth
authors.forename: Tobias
authors.initials: T
authors.lastname: Maetzig
authors.forename: Melanie
authors.initials: M
authors.lastname: Galla
authors.forename: Christopher
authors.initials: C
authors.lastname: Baum
authors.forename: Axel
authors.initials: A
authors.lastname: Schambach
mesh_terms: D001355:Alpharetrovirus / Q000235:genetics / Q000502:physiology*; D000818:Animals; D002460:Cell Line; D002478:Cells, Cultured; D015870:Gene Expression; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D051379:Mice; D011401:Promoter Regions, Genetic; D012367:RNA, Viral / Q000235:genetics; D020079:Terminal Repeat Sequences / Q000235:genetics*; D019076:Transgenes; D019065:Virus Assembly
chemical_list: D012367:RNA, Viral
references.citation: Gene Ther. 2001 Mar;8(6):477-86
references.pmid: 11313827
references.citation: Cell. 2002 Aug 23;110(4):521-9
references.pmid: 12202041
references.citation: Expert Opin Biol Ther. 2009 Nov;9(11):1427-36
references.pmid: 19743892
references.citation: J Virol. 1998 Nov;72(11):8463-71
references.pmid: 9765382
references.citation: Hum Gene Ther. 2007 Aug;18(8):691-700
references.pmid: 17655493
references.citation: J Clin Invest. 2008 Sep;118(9):3143-50
references.pmid: 18688286
references.citation: J Virol. 1982 Nov;44(2):725-30
references.pmid: 6183452
references.citation: J Virol. 2004 Aug;78(16):8421-36
references.pmid: 15280451
references.citation: J Virol. 1996 Oct;70(10):6642-52
references.pmid: 8794299
references.citation: J Exp Med. 1992 Oct 1;176(4):1125-35
references.pmid: 1383375
references.citation: Blood. 2003 Dec 1;102(12):3934-7
references.pmid: 12881303
references.citation: PLoS Biol. 2004 Aug;2(8):E234
references.pmid: 15314653
references.citation: Methods Cell Biol. 1994;43 Pt A:99-112
references.pmid: 7823872
references.citation: Mol Ther. 2006 Feb;13(2):391-400
references.pmid: 16226060
references.citation: J Clin Invest. 2008 Sep;118(9):3132-42
references.pmid: 18688285
references.citation: Mol Ther. 2009 Nov;17(11):1919-28
references.pmid: 19672245
references.citation: J Virol. 1995 Dec;69(12):7541-7
references.pmid: 7494260
references.citation: J Virol. 1987 Oct;61(10):3004-12
references.pmid: 3041020
references.citation: J Virol. 1983 Dec;48(3):667-75
references.pmid: 6313966
references.citation: EMBO J. 1985 Apr;4(4):949-56
references.pmid: 2990916
references.citation: Gene Ther. 2010 Mar;17(3):400-11
references.pmid: 19847204
references.citation: Blood. 2006 Oct 15;108(8):2545-53
references.pmid: 16825499
references.citation: Gene Ther. 2004 Jun;11(11):879-81
references.pmid: 15057265
references.citation: Mol Ther. 2008 Sep;16(9):1617-23
references.pmid: 18578011
references.citation: Mol Ther. 2008 Mar;16(3):590-8
references.pmid: 18180772
references.citation: Gene Ther. 2000 Jun;7(12):1063-6
references.pmid: 10871756
references.citation: Exp Hematol. 2006 May;34(5):588-92
references.pmid: 16647564
references.citation: J Virol. 2002 Feb;76(3):1488-95
references.pmid: 11773421
references.citation: Folia Biol (Praha). 2004;50(3-4):107-19
references.pmid: 15373344
references.citation: Cell. 1988 Nov 4;55(3):447-58
references.pmid: 2846182
references.citation: Nucleic Acids Res. 2001 May 1;29(9):e45
references.pmid: 11328886
references.citation: Blood. 2002 Aug 1;100(3):823-32
references.pmid: 12130492
references.citation: Virology. 1984 Jul 15;136(1):89-99
references.pmid: 6330999
references.citation: J Virol. 2009 Jan;83(1):283-94
references.pmid: 18945765
references.citation: DNA Res. 2001 Oct 31;8(5):221-6
references.pmid: 11759842
references.citation: J Virol. 2000 Nov;74(22):10822-6
references.pmid: 11044131
references.citation: J Virol. 1996 Jun;70(6):3834-43
references.pmid: 8648719
references.citation: J Mol Biol. 1998 Nov 27;284(2):205-25
references.pmid: 9813113
references.citation: Gene Ther. 2006 Apr;13(7):641-5
references.pmid: 16355114
references.citation: Science. 2003 Jun 13;300(5626):1749-51
references.pmid: 12805549
references.citation: Mol Ther. 2008 Apr;16(4):718-25
references.pmid: 18334985
references.citation: Genomics. 2004 Jan;83(1):76-84
references.pmid: 14667811
references.citation: Nucleic Acids Res. 1995 Feb 25;23(4):628-33
references.pmid: 7899083
references.citation: J Clin Invest. 2009 Apr;119(4):964-75
references.pmid: 19307726
references.citation: J Virol. 1998 Dec;72(12):9873-80
references.pmid: 9811723
references.citation: Gene Ther. 2006 Nov;13(21):1524-33
references.pmid: 16763662